resistance
-
An expert's opinion: Interview with Dr Pablo Moral on the fight against antimicrobial resistance
Dr Pablo Moral is a bioscientist working at GSK Global Health Medicines. As the industrial lead of the EU-funded END2AMR project, a European consortium launched in 2026 to pioneer novel therapies against drug-resistant pathogens, Dr. Moral stands at the forefront of the fight against antimicrobial resistance,... -
An expert's opinion: Interview with Prof. Christian Giske on the fight against antimicrobial resistance
Professor Christian Giske is a Norwegian microbiologist, Professor of Clinical Bacteriology at the Karolinska Institutet in Sweden, and Head of Antimicrobial Resistance and Healthcare-Associated Infections at the European Centre for Disease Prevention and Control (ECDC). He has spent his career mapping... -
European Antibiotic Awareness Day turns 18: What have we learnt so far?
Since the discovery of bacterial infections in the first half of the 20th century, humanity has relied on the great healing capabilities of antibiotics as a cornerstone of modern medicine - perhaps too heavily. Excessive antibiotic consumption has accelerated antimicrobial resistance (AMR) in bacteria,... -
Phage therapy: From last resort to routine medicine
Ever more often, bacteria, viruses, fungi and parasites stop responding to the medicines designed to treat them, such as antibiotics. This antimicrobial resistance (AMR) poses a growing threat, with an estimated 8.22 million deaths globally in 2050. Armed conflicts are escalating the situation: conflicts... -
A scientist's opinion: interview with Prof. Dr. Jakob Zinsstag-Klopfenstein on ‘One Health’
Epidemiology Professor Jakob Zinsstag (University of Basel, Switzerland) leads a research group focused on the interface of human and animal health, particularly zoonoses and the health of nomadic populations, under the ‘One Health’ approach. He also is a member of the One Health High Level Expert Panel... -
Tackling antimicrobial resistance: from science to policy
Antimicrobial resistance, whereby antibiotics are no longer effective against bacteria or other microorganisms, is a growing problem. Every year, 33,000 people in the EU die from infectious diseases that cannot be treated with available medication. The European Parliament's Panel for the Future of... -
EU Project : CARTNET
CARTNET : This project trains young researchers in Europe to address serious and global problems of antibiotic resistance. CARTNET, which started begin 2018, will focus on alternative approaches to handle antibiotic resistance and treating resistant infections in both humans and animals. It will provide...